77 filings
10-Q
2024 Q1
VOR
Vor Biopharma Inc
Quarterly report
9 May 24
4:01pm
DEFA14A
VOR
Vor Biopharma Inc
2 May 24
Additional proxy soliciting materials
4:08pm
8-K
VOR
Vor Biopharma Inc
2 May 24
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
4:07pm
ARS
2023 FY
VOR
Vor Biopharma Inc
9 Apr 24
Annual report to shareholders
4:10pm
DEFA14A
VOR
Vor Biopharma Inc
9 Apr 24
Additional proxy soliciting materials
4:07pm
S-8
v2tbj9591my887 fs
20 Mar 24
Registration of securities for employees
6:20pm
8-K
d89xf3ac7pdh x92ix
5 Jan 24
Other Events
5:03pm
8-K
cy45n wlr
2 Nov 23
Multiple Clinical and Preclinical Presentations at ASH 2023
9:10am
S-8
h0mf8
30 Aug 23
Registration of securities for employees
4:51pm
8-K
uzufl41u
9 Jun 23
Regulation FD Disclosure
7:41am
8-K
en75x3
26 May 23
Submission of Matters to a Vote of Security Holders
4:02pm
ARS
cd26wmd
14 Apr 23
Annual report to shareholders
4:10pm
DEFA14A
6wyzqy0sj h8kodpa
14 Apr 23
Additional proxy soliciting materials
4:07pm
8-K
38f8 j8n6qof545f0
14 Apr 23
Departure of Directors or Certain Officers
4:01pm